Detalles de la búsqueda
1.
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.
Blood
; 137(16): 2161-2170, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171487
2.
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study.
Blood
; 134(17): 1395-1405, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471376
3.
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
Blood
; 131(4): 397-407, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29141948
4.
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies.
Blood
; 129(1): 88-99, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27784673
5.
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.
Lancet Oncol
; 19(4): 486-496, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29475723
6.
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
Lancet Oncol
; 19(2): 257-266, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29276022
7.
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
Br J Haematol
; 177(2): 243-253, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220479
8.
Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma.
Br J Haematol
; 180(5): 757-760, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27984643
9.
Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant MYD88 and wildtype CD79.
Haematologica
; 102(7): e275-e277, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341730
10.
Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma.
Exp Hematol Oncol
; 10(1): 15, 2021 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602316
11.
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.
Mol Cancer Ther
; 20(8): 1422-1430, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34108263
12.
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest.
Oncotarget
; 11(37): 3432-3442, 2020 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32973968
13.
Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series.
Ther Adv Hematol
; 11: 2040620720947340, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33062232
14.
Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.
Curr Hematol Malig Rep
; 14(4): 219-227, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231778
15.
Microclimate exerts greater control over litter decomposition and enzyme activity than litter quality in an alpine forest-tundra ecotone.
Sci Rep
; 8(1): 14998, 2018 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30301949
16.
Global analysis of gene function in yeast by quantitative phenotypic profiling.
Mol Syst Biol
; 2: 2006.0001, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16738548
17.
Solvent-filled matrix polyelectrolyte capsules: preparation, structure and dynamics.
Soft Matter
; 3(10): 1293-1299, 2007 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32900095
18.
Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use.
Leuk Lymphoma
; 58(11): 2548-2557, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28738754
19.
Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity.
Blood Adv
; 6(14): 4157-4161, 2022 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35613464
20.
Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae.
Mol Cancer Res
; 3(12): 669-77, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16380504